The global demand for Autoinjectors Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
An autoinjector is a medical device that enables the self-administration of a particular drug with less anxiety and stress. It is easy to use a spring-loaded syringe that is generally disposable. It can be used for intramuscular and subcutaneous injection, typically administered into the buttocks or the thigh. It comes in different shapes and sizes along with several features like adjustable injection depth, a drug inspection window, retractable needle, automated voice instruction, and color-coded spent indicator. This device is often used by military personnel for first aid to protect themselves from chemical warfare agents.
The widespread increase in self-administration of drug therapies among the global population will be the key driving force behind this market's growth. The aim to reduce the number of hospital visits and the expenses involved by health insurance agencies will further propel the autoinjectors' market among chronic patients. This market's main attractive segment is the growing trend to treat rheumatoid arthritis, multiple sclerosis, and diabetic patients using injectable self-administration. The various advantages of an autoinjector can save considerable time and money for the pharmaceutical and biopharmaceutical industries. The challenges faced by this market are related to the materials used for the manufacture of springs and other precision metal components used in an autoinjector
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of autoinjectors.
The entire autoinjectors market has been sub-categorized into therapy, type and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
- Rheumatoid Arthritis
- Multiple Sclerosis
- Other Therapies
- Disposable Autoinjectors
- Reusable Autoinjectors
- Home Care Settings
- Hospital & Clinics
This section covers regional segmentation which accentuates on current and future demand for autoinjectors market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Autoinjectors Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the autoinjectors market include Eli Lilly, Biogen Idec, Pfizer, Inc., Mylan N.V., Sanofi, Owen Mumford, Teva Pharmaceutical, Amgen, Ypsomed, Abbvie. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.